Patent 9447401 was granted and assigned to Halozyme, Inc. on September, 2016 by the United States Patent and Trademark Office.
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.